Ovarian Cancer
2017 Ovarian Cancer Research Highlights
- Evaluation of DNA Repair Function as a Predictor of Response in a Clinical Trial of PARP Inhibitor Monotherapy for Recurrent Ovarian Carcinoma
- Towards Understanding Ovarian Cancer Progression and Chemotherapy Resistance
- Chip-Based Magnetic Imager for Molecular Profiling of Ovarian Cancer Cells
- The Clinical Development Award: Accelerating Ovarian Cancer Research into Clinical Application
- Combination Therapy of JO-c and PEGylated Liposomal Doxorubicin/DoxilTTM in Ovarian Cancer Patients
Last updated Thursday, May 26, 2022